Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Diagnostic Radiopharmaceuticals and Contrast Media market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.9% during the forecast period.
This report presents the market size and development trends by detailing the Diagnostic Radiopharmaceuticals and Contrast Media market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Diagnostic Radiopharmaceuticals and Contrast Media market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Diagnostic Radiopharmaceuticals and Contrast Media industry and will help you to build a panoramic view of the industrial development.
Diagnostic Radiopharmaceuticals and Contrast Media Market, By Type:
Radiopharmaceuticals
Contrast Media
Diagnostic Radiopharmaceuticals and Contrast Media Market, By Application:
Diagnostic
Therapeutic
Ionizing Radiation based Radioimaging
Non-Ionizing Radiation based Radioimaging
Some of the leading players are as follows:
Guerbet
Bracco Imaging
GE Healthcare
Lantheus
Bayer Healthcare
Mallinckrodt
Medtronic
Amag Pharmaceuticals
Nordion
Daiichi Sankyo
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Diagnostic Radiopharmaceuticals and Contrast Media Market: Technology Type Analysis
-
4.1 Diagnostic Radiopharmaceuticals and Contrast Media Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Diagnostic Radiopharmaceuticals and Contrast Media Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Radiopharmaceuticals
4.3.2 Contrast Media
5 Diagnostic Radiopharmaceuticals and Contrast Media Market: Product Analysis
-
5.1 Diagnostic Radiopharmaceuticals and Contrast Media Product Market Share Analysis, 2018 & 2026
-
5.2 Diagnostic Radiopharmaceuticals and Contrast Media Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Diagnostic Radiopharmaceuticals and Contrast Media Market: Application Analysis
-
6.1 Diagnostic Radiopharmaceuticals and Contrast Media Application Market Share Analysis, 2018 & 2026
-
6.2 Diagnostic Radiopharmaceuticals and Contrast Media Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Diagnostic
6.3.2 Therapeutic
6.3.3 Ionizing Radiation based Radioimaging
6.3.4 Non-Ionizing Radiation based Radioimaging
7 Diagnostic Radiopharmaceuticals and Contrast Media Market: Regional Analysis
-
7.1 Diagnostic Radiopharmaceuticals and Contrast Media Regional Market Share Analysis, 2018 & 2026
-
7.2 Diagnostic Radiopharmaceuticals and Contrast Media Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Guerbet
9.1.1 Guerbet Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Bracco Imaging
9.2.1 Bracco Imaging Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 GE Healthcare
9.3.1 GE Healthcare Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Lantheus
9.4.1 Lantheus Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Bayer Healthcare
9.5.1 Bayer Healthcare Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Mallinckrodt
9.6.1 Mallinckrodt Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Medtronic
9.7.1 Medtronic Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Amag Pharmaceuticals
9.8.1 Amag Pharmaceuticals Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Nordion
9.9.1 Nordion Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Daiichi Sankyo
9.10.1 Daiichi Sankyo Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 85 Figures and 158 Tables)
Figure Radiopharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media market, 2015 - 2026 (USD Million)
Figure Contrast Media Diagnostic Radiopharmaceuticals and Contrast Media market, 2015 - 2026 (USD Million)
Figure Diagnostic market, 2015 - 2026 (USD Million)
Figure Therapeutic market, 2015 - 2026 (USD Million)
Figure Ionizing Radiation based Radioimaging market, 2015 - 2026 (USD Million)
Figure Non-Ionizing Radiation based Radioimaging market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Diagnostic Radiopharmaceuticals and Contrast Media market, by country, 2015 - 2026 (USD Million)
-
Table North America Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table North America Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table North America Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Canada Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Canada Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Europe Diagnostic Radiopharmaceuticals and Contrast Media market, by country, 2015 - 2026 (USD Million)
-
Table Europe Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Europe Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Europe Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Germany Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Germany Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table France Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table France Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Italy Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Italy Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Spain Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Spain Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table China Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table China Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Japan Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Japan Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table India Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table India Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Diagnostic Radiopharmaceuticals and Contrast Media market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table MEA Diagnostic Radiopharmaceuticals and Contrast Media market, by country, 2015 - 2026 (USD Million)
-
Table MEA Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table MEA Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table MEA Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Diagnostic Radiopharmaceuticals and Contrast Media market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Diagnostic Radiopharmaceuticals and Contrast Media market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Diagnostic Radiopharmaceuticals and Contrast Media market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Guerbet Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bracco Imaging Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GE Healthcare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lantheus Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Healthcare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mallinckrodt Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medtronic Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amag Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Nordion Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Daiichi Sankyo Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
